y 27632 has been researched along with everolimus in 1 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (everolimus) | Trials (everolimus) | Recent Studies (post-2010) (everolimus) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 5,631 | 1,289 | 4,579 |
Protein | Taxonomy | y 27632 (IC50) | everolimus (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 2 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0022 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, HR; Hsu, YH; Huang, HP | 1 |
1 other study(ies) available for y 27632 and everolimus
Article | Year |
---|---|
The uremic toxin p-cresol promotes the invasion and migration on carcinoma cells via Ras and mTOR signaling.
Topics: Amides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cresols; Everolimus; Humans; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyridines; ras Proteins; Signal Transduction; TOR Serine-Threonine Kinases; Uremia; Urinary Bladder Neoplasms; Wound Healing | 2019 |